Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06751082

Real World Observational Study of Sotatercept for Pulmonary Hypertension

Sotatercept Pulmonary Hypertension Observational Registry

Status
Recruiting
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study seeks to describe the real world initial experience with sotatercept in the treatment of pulmonary hypertension.

Conditions

Timeline

Start date
2025-01-20
Primary completion
2027-03-01
Completion
2027-03-01
First posted
2024-12-27
Last updated
2026-04-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06751082. Inclusion in this directory is not an endorsement.